Location History:
- Newton, MA (US) (2003)
- Boston, MA (US) (1998 - 2004)
Company Filing History:
Years Active: 1998-2004
Title: Inmin Wu: Innovator in Antiangiogenic Research
Introduction
Inmin Wu is a prominent inventor based in Boston, MA (US), known for his significant contributions to the field of antiangiogenic research. With a total of 5 patents to his name, Wu has made strides in developing innovative solutions to combat diseases related to angiogenesis.
Latest Patents
Wu's latest patents include groundbreaking work on antiangiogenic peptides and compositions. One of his notable inventions provides an antiangiogenic polypeptide with a specific amino acid sequence that effectively inhibits endothelial cell proliferation. This polypeptide demonstrates varying levels of inhibition, achieving up to 95% inhibition of bFGF-stimulated endothelial cell proliferation at a concentration of 5 Tg/ml. Additionally, he has developed pharmaceutical compositions comprising troponin subunits, fragments, and analogs, aimed at treating diseases involving angiogenesis.
Career Highlights
Inmin Wu is affiliated with the Children's Medical Center Corporation, where he continues to advance his research and innovations. His work has garnered attention in the medical community, particularly for its potential applications in treating various disorders linked to abnormal blood vessel growth.
Collaborations
Wu collaborates with esteemed colleagues, including Marsha A Moses and Robert Samuel Langer, who are also recognized for their contributions to medical research and innovation.
Conclusion
Inmin Wu's work in antiangiogenic research exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of continued research in developing effective treatments for diseases related to angiogenesis.